{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:53:08Z","timestamp":1787237588481,"version":"build-2736575974"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,2]]},"DOI":"10.7759\/cureus.100639","type":"journal-article","created":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T01:23:53Z","timestamp":1767403433000},"source":"Crossref","is-referenced-by-count":2,"title":["CYP24A1 Deficiency Presenting With Hypercalcemia and Hypervitaminosis D in Pregnancy: A Case Report"],"prefix":"10.7759","author":[{"given":"Susanne U","family":"Trost","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn","family":"Burmeister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.07s221","article-title":"Vitamin D toxicity, policy, and science","volume":"22","author":"Vieth R","year":"2007","unstructured":"Vieth R. Vitamin D toxicity, policy, and science. J Bone Miner Res. 2007, 22:V64-8. 10.1359\/jbmr.07s221","journal-title":"J Bone Miner Res"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00550","article-title":"Vitamin D toxicity - a clinical perspective","volume":"9","author":"Marcinowska-Suchowierska E","year":"2018","unstructured":"Marcinowska-Suchowierska E, Kupisz-Urba\u0144ska M, \u0141ukaszkiewicz J, P\u0142udowski P, Jones G. Vitamin D toxicity - a clinical perspective. Front Endocrinol (Lausanne). 2018, 9:550. 10.3389\/fendo.2018.00550","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(53)90187-1","article-title":"Idiopathic hypercalcaemia in infants","volume":"265","author":"Lightwood R","year":"1953","unstructured":"Lightwood R, Stapleton T. Idiopathic hypercalcaemia in infants. Lancet. 1953, 265:255-6. 10.1016\/s0140-6736(53)90187-1","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1103864","article-title":"Mutations in CYP24A1 and idiopathic infantile hypercalcemia","volume":"365","author":"Schlingmann KP","year":"2011","unstructured":"Schlingmann KP, Kaufmann M, Weber S, et al.. Mutations in CYP24A1 and idiopathic infantile hypercalcemia. N Engl J Med. 2011, 365:410-21. 10.1056\/NEJMoa1103864","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-21-0713","article-title":"Hypercalcemia due to CYP24A1 mutations: a systematic descriptive review","volume":"186","author":"Cappellani D","year":"2021","unstructured":"Cappellani D, Brancatella A, Morganti R, et al.. Hypercalcemia due to CYP24A1 mutations: a systematic descriptive review. Eur J Endocrinol. 2021, 186:137-49. 10.1530\/EJE-21-0713","journal-title":"Eur J Endocrinol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms251810003","article-title":"Targeting calcitriol metabolism in acute vitamin D toxicity - a comprehensive review and clinical insight","volume":"25","author":"Aberger S","year":"2024","unstructured":"Aberger S, Schreiber N, Pilz S, Eller K, Rosenkranz AR, Kirsch AH. Targeting calcitriol metabolism in acute vitamin D toxicity - a comprehensive review and clinical insight. Int J Mol Sci. 2024, 25:10003. 10.3390\/ijms251810003","journal-title":"Int J Mol Sci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2018-1208","article-title":"CYP24A1 and SLC34A1 genetic defects associated with idiopathic infantile hypercalcemia: from genotype to phenotype","volume":"57","author":"De Paolis E","year":"2019","unstructured":"De Paolis E, Scaglione GL, De Bonis M, Minucci A, Capoluongo E. CYP24A1 and SLC34A1 genetic defects associated with idiopathic infantile hypercalcemia: from genotype to phenotype. Clin Chem Lab Med. 2019, 57:1650-67. 10.1515\/cclm-2018-1208","journal-title":"Clin Chem Lab Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2016.08.027","article-title":"Hypercalcemia in patients with Williams-Beuren syndrome","volume":"178","author":"Sindhar S","year":"2016","unstructured":"Sindhar S, Lugo M, Levin MD, et al.. Hypercalcemia in patients with Williams-Beuren syndrome. J Pediatr. 2016, 178:254-60. 10.1016\/j.jpeds.2016.08.027","journal-title":"J Pediatr"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-4388","article-title":"Clinical utility of simultaneous quantitation of 25-hydroxyvitamin D and 24,25-dihydroxyvitamin D by LC-MS\/MS involving derivatization with DMEQ-TAD","volume":"99","author":"Kaufmann M","year":"2014","unstructured":"Kaufmann M, Gallagher JC, Peacock M, et al.. Clinical utility of simultaneous quantitation of 25-hydroxyvitamin D and 24,25-dihydroxyvitamin D by LC-MS\/MS involving derivatization with DMEQ-TAD. J Clin Endocrinol Metab. 2014, 99:2567-74. 10.1210\/jc.2013-4388","journal-title":"J Clin Endocrinol Metab"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2015.244459","article-title":"LC-MS\/MS for identifying patients with CYP24A1 mutations","volume":"62","author":"Ketha H","year":"2016","unstructured":"Ketha H, Kumar R, Singh RJ. LC-MS\/MS for identifying patients with CYP24A1 mutations. Clin Chem. 2016, 62:236-42. 10.1373\/clinchem.2015.244459","journal-title":"Clin Chem"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/nu14122518","article-title":"Hypercalcemia in pregnancy due to CYP24A1 mutations: case report and review of the literature","volume":"14","author":"Pilz S","year":"2022","unstructured":"Pilz S, Theiler-Schwetz V, Pludowski P, et al.. Hypercalcemia in pregnancy due to CYP24A1 mutations: case report and review of the literature. Nutrients. 2022, 14:22518. 10.3390\/nu14122518","journal-title":"Nutrients"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1515\/jpem-2023-0147","article-title":"Clinical heterogeneity and therapeutic options for\u00a0idiopathic infantile hypercalcemia caused by\u00a0CYP24A1 pathogenic variant","volume":"36","author":"Zheng Z","year":"2023","unstructured":"Zheng Z, Wu Y, Wu H, Jin J, Luo Y, Cao S, Shan X. Clinical heterogeneity and therapeutic options for\u00a0idiopathic infantile hypercalcemia caused by\u00a0CYP24A1 pathogenic variant. J Pediatr Endocrinol Metab. 2023, 36:999-1011. 10.1515\/jpem-2023-0147","journal-title":"J Pediatr Endocrinol Metab"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2021.07.009","article-title":"Hypercalcemia in pregnancy","volume":"50","author":"Dandurand K","year":"2021","unstructured":"Dandurand K, Ali DS, Khan AA. Hypercalcemia in pregnancy. Endocrinol Metab Clin North Am. 2021, 50:753-68. 10.1016\/j.ecl.2021.07.009","journal-title":"Endocrinol Metab Clin North Am"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s00394-023-03124-w","article-title":"Long-term supplementation with 3200 to 4000\u00a0IU of vitamin D daily and adverse events: a systematic review and meta-analysis of randomized controlled trials","volume":"62","author":"Zittermann A","year":"2023","unstructured":"Zittermann A, Trummer C, Theiler-Schwetz V, Pilz S. Long-term supplementation with 3200 to 4000\u00a0IU of vitamin D daily and adverse events: a systematic review and meta-analysis of randomized controlled trials. Eur J Nutr. 2023, 62:1833-44. 10.1007\/s00394-023-03124-w","journal-title":"Eur J Nutr"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-4387","article-title":"CYP24A1 mutations in a cohort of hypercalcemic patients: evidence for a recessive trait","volume":"100","author":"Molin A","year":"2015","unstructured":"Molin A, Baudoin R, Kaufmann M, et al.. CYP24A1 mutations in a cohort of hypercalcemic patients: evidence for a recessive trait. J Clin Endocrinol Metab. 2015, 100:E1343-52. 10.1210\/jc.2014-4387","journal-title":"J Clin Endocrinol Metab"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1172\/JCI108459","article-title":"Radioligand receptor assay for 25-hydroxyvitamin D2\/D3 and 1 alpha, 25-dihydroxyvitamin D2\/D3","volume":"58","author":"Hughes MR","year":"1976","unstructured":"Hughes MR, Baylink DJ, Jones PG, Haussler MR. Radioligand receptor assay for 25-hydroxyvitamin D2\/D3 and 1 alpha, 25-dihydroxyvitamin D2\/D3. J Clin Invest. 1976, 58:61-70. 10.1172\/JCI108459","journal-title":"J Clin Invest"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199204303261801","article-title":"Hypervitaminosis D associated with drinking milk","volume":"326","author":"Jacobus CH","year":"1992","unstructured":"Jacobus CH, Holick MF, Shao Q, et al.. Hypervitaminosis D associated with drinking milk. N Engl J Med. 1992, 326:1173-7. 10.1056\/NEJM199204303261801","journal-title":"N Engl J Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/nu10080953","article-title":"Development of vitamin D toxicity from overcorrection of vitamin D deficiency: a review of case reports","volume":"10","author":"Galior K","year":"2018","unstructured":"Galior K, Grebe S, Singh R. Development of vitamin D toxicity from overcorrection of vitamin D deficiency: a review of case reports. Nutrients. 2018, 10:80953. 10.3390\/nu10080953","journal-title":"Nutrients"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1093\/jbmrpl\/ziaf102","article-title":"Hypercalcemia due to CYP24A1 variants in five unrelated patients: diagnostic and clinical considerations","volume":"9","author":"Sarvaideo JL","year":"2025","unstructured":"Sarvaideo JL, Col\u00f3n-Franco JM, Kumar R, Shaker JL. Hypercalcemia due to CYP24A1 variants in five unrelated patients: diagnostic and clinical considerations. JBMR Plus. 2025, 9:ziaf102. 10.1093\/jbmrpl\/ziaf102","journal-title":"JBMR Plus"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3390\/jpm15040128","article-title":"Genetic polymorphisms in cytochrome P450 enzymes involved in vitamin D metabolism and the vitamin D receptor: their clinical relevance","volume":"15","author":"Jarrar Y","year":"2025","unstructured":"Jarrar Y, Alhammadin G, Lee SJ. Genetic polymorphisms in cytochrome P450 enzymes involved in vitamin D metabolism and the vitamin D receptor: their clinical relevance. J Pers Med. 2025, 15:40128. 10.3390\/jpm15040128","journal-title":"J Pers Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/437681-cyp24a1-deficiency-presenting-with-hypercalcemia-and-hypervitaminosis-d-in-pregnancy-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T01:23:54Z","timestamp":1767403434000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/437681-cyp24a1-deficiency-presenting-with-hypercalcemia-and-hypervitaminosis-d-in-pregnancy-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,2]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.100639","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,2]]}}}